Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond R Townsend

Showing results (201-210 of 316) with videos related to

Pageof 32
Sort By:
Hypertension (Dallas, Tex. : 1979)|August 5, 2024
Renal Denervation for the Treatment of Hypertension: A Scientific Statement From the American Heart AssociationJennifer L Cluett, Olivia Blazek, Angela L Brown, et al.
Lancet (London, England)|May 28, 2018
Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trialDavid E Kandzari, Michael Böhm, Felix Mahfoud, et al.
American Journal of Hypertension|September 26, 2009
Aortic pulse pressure is associated with carotid IMT in chronic kidney disease: report from Chronic Renal Insufficiency CohortStephanie S DeLoach, Lawrence J Appel, Jing Chen, et al.
Journal of the American Heart Association|February 22, 2017
Isosorbide Dinitrate, With or Without Hydralazine, Does Not Reduce Wave Reflections, Left Ventricular Hypertrophy, or Myocardial Fibrosis in Patients With Heart Failure With Preserved Ejection FractionPayman Zamani, Scott Akers, Haideliza Soto-Calderon, et al.
European Heart Journal|November 7, 2022
Hypertension management in patients with cardiovascular comorbiditiesLucas Lauder, Felix Mahfoud, Michel Azizi, et al.
Journal of Human Hypertension|January 11, 2024
Prognostic utility of rhythmic components in 24-h ambulatory blood pressure monitoring for the risk stratification of chronic kidney disease patients with cardiovascular co-morbidityNadim El Jamal, Thomas G Brooks, Jordana Cohen, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2023
Prognostic utility of rhythmic components in 24-hour ambulatory blood pressure monitoring for the risk stratification of chronic kidney disease patients with cardiovascular co-morbidityNadim E Jamal, Thomas G Brooks, Jordana Cohen, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 17, 2019
Race and Mortality in CKD and Dialysis: Findings From the Chronic Renal Insufficiency Cohort (CRIC) StudyElaine Ku, Wei Yang, Charles E McCulloch, et al.
The American Journal of Cardiology|April 3, 2012
Risk factors for peripheral arterial disease among patients with chronic kidney diseaseJing Chen, Emile R Mohler, Dawei Xie, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 20, 2015
Traditional and non-traditional risk factors for incident peripheral arterial disease among patients with chronic kidney diseaseJing Chen, Emile R Mohler, Dawei Xie, et al.
Pageof 32

Showing results (201-210 of 316) with videos related to

Sort By:
Pageof 32
Hypertension (Dallas, Tex. : 1979)|August 5, 2024
Renal Denervation for the Treatment of Hypertension: A Scientific Statement From the American Heart AssociationJennifer L Cluett, Olivia Blazek, Angela L Brown, et al.
Lancet (London, England)|May 28, 2018
Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trialDavid E Kandzari, Michael Böhm, Felix Mahfoud, et al.
American Journal of Hypertension|September 26, 2009
Aortic pulse pressure is associated with carotid IMT in chronic kidney disease: report from Chronic Renal Insufficiency CohortStephanie S DeLoach, Lawrence J Appel, Jing Chen, et al.
Journal of the American Heart Association|February 22, 2017
Isosorbide Dinitrate, With or Without Hydralazine, Does Not Reduce Wave Reflections, Left Ventricular Hypertrophy, or Myocardial Fibrosis in Patients With Heart Failure With Preserved Ejection FractionPayman Zamani, Scott Akers, Haideliza Soto-Calderon, et al.
European Heart Journal|November 7, 2022
Hypertension management in patients with cardiovascular comorbiditiesLucas Lauder, Felix Mahfoud, Michel Azizi, et al.
Journal of Human Hypertension|January 11, 2024
Prognostic utility of rhythmic components in 24-h ambulatory blood pressure monitoring for the risk stratification of chronic kidney disease patients with cardiovascular co-morbidityNadim El Jamal, Thomas G Brooks, Jordana Cohen, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2023
Prognostic utility of rhythmic components in 24-hour ambulatory blood pressure monitoring for the risk stratification of chronic kidney disease patients with cardiovascular co-morbidityNadim E Jamal, Thomas G Brooks, Jordana Cohen, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 17, 2019
Race and Mortality in CKD and Dialysis: Findings From the Chronic Renal Insufficiency Cohort (CRIC) StudyElaine Ku, Wei Yang, Charles E McCulloch, et al.
The American Journal of Cardiology|April 3, 2012
Risk factors for peripheral arterial disease among patients with chronic kidney diseaseJing Chen, Emile R Mohler, Dawei Xie, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 20, 2015
Traditional and non-traditional risk factors for incident peripheral arterial disease among patients with chronic kidney diseaseJing Chen, Emile R Mohler, Dawei Xie, et al.
Pageof 32